What's new

Biopharmaceuticals and medical devices from Eiffelland (2012)

Rheinbund

Established Nation
Joined
Oct 30, 2006
Messages
11,833
Location
Rotterdam, Netherlands
Capital
Fehrbellin
The Eiffellandian biopharmaceutical industry consists of four branches:

- Pharmaceutics;
- Medical devices;
- Medical equipment and equipment for laboratories;
- Contract Research Organisations.

Pharmaceutics
Novartis produces and invents antibiotics, antiviral medications, medications for Asthma and COPD, antiflogistics, dermatologica, vaccines, coagulants, anticoagulants, heart medications, medications for haematologic diseases, bowel medications, bandages, medications for endocrinological diseases, cancer medications, psychopharmaca, pain killers and products for dentistry.Novartis is also very active on the tooth paste and tooth brushes market. It cooperates with Rowenta (part of the Rathenau Gruppe) for the production of electric tooth brushes.

Medical devices
Medtronic produces and invents pacemakers, bone reconstruction materials (nowadays mainly bone cement), other medical implants like medication pumps, and infusion pumps.A recent invention is a chip technique with which neck fracture patients can move a cursor on a computer screen. The chip is implanted on the motocortex of the brain, and the patient controls the computer by imagining that he is moving his fingers and/or arms.

Hospital and laboratory equipment
Eppendorf is the company in this sector. It produces all kinds of laboratory and hospital equipment, for instance injection needles, infusion needles, micropipettes, ELISA equipment, cell separation techniques, micro-infusion techniques on cell level, X-ray equipment, CT scan equipment, MRI scan equipment, PET scan equipment, endoscopy equipment, FACS equipment, ECG equipment, echography equipment, defibrillators and so on.Where the CT-scan and the MRI-scan can make pictures of the anatomy, the PET-scan makes it possible to investigate the physiology by following radioactively labeled substances in the body of the patient. The labeled substance emits positrones, which are detected by the scan. An implementation for this technique is the following. Heart muscle tissue usually takes fatty acids to metabolise, but it can also run on glucose. If you want to know if a piece of the heart after a narrowing in the coronary artery is still alive, then you look if that piece of the heart takes up the labeled glucose molecules. If YES, then you prepare for a heart operation. If NO, then you know that an operation won't cure your patient.Eppendorf also equips the MEDEVAC planes, used to carry severely wounded people. These planes are even equipped with Intensive Care Units.

Contract research organisations
It is always difficult to conduct a clinical study with a new medication properly. Generally, regulatory authorities are not very easy in accepting new medications. The dramas around Softenone (Thalidomide) and DES told us that we have to be careful with introducing new medicines. Parexel is a full-service Contract Research Organisation for the pharmaceutical industry. It has much experience in conducting Phase I, II, III and IV studies. The following services are offered: - Protocol writing. - CRF design. - Database construction. - Shipment of trial medication. - Investigator recruitment. - Randomisation of patients. - Monitoring. - Datamanagement. - Serious Adverse Event reconciliation. - Quality assurance. - Statistical analysis. - Medical writing. We also detach project managers, CRAs, datamanagers, SAS-programmers, statisticians, medical writers and auditors. We can manage both paper and EDC studies. And of course, we can manage complete studies. The system we use for datamanagement, is ClinPlus Data Management (CPDM), based on the database system SAS.
 

Rheinbund

Established Nation
Joined
Oct 30, 2006
Messages
11,833
Location
Rotterdam, Netherlands
Capital
Fehrbellin
Press release

Eppendorf introduces a new system of injecting vaccines. Currently, most vaccines are applied via intramuscular injections. The new system injects vaccines through the skin with high pressure. The advantage of this new system is that the fluids containing the vaccine spreads through the tissue in a better way, because of which only 20% of the fluid needed for immunisation via an intramuscular injection is needed. This means that four times more people can be immunised with the same amount of vaccination material. This new vaccination injection system will reduce the cost of vaccination campaigns dramaticly.
 
Joined
Feb 25, 2008
Messages
496
Novo Nordisk Inc - Saving Lives Since 1902

Novo Nordisk, Kelas' largest pharmaceutical company is interested in distributing the diverse products of the Eiffellandian bio-pharmaceutical industry in our own market.

We are particularly interested in manufacturing under license your high-pressure injection technology as we believe it could provide a revolutionary means to deliver drugs such as insulin and other injectable treatments beyond vaccines. We would happily make this a joint-project and share in all benefits it may provide.
 

Rheinbund

Established Nation
Joined
Oct 30, 2006
Messages
11,833
Location
Rotterdam, Netherlands
Capital
Fehrbellin
Eppendorf A.G.

We didn't think of the possibility to use our high-pressure injection device for insulin and other medications to be injected. We want to make clear that our device is not suitable for medications to be injected intravenously, because those medications have to become biologically available in far less time than medications to be injected intramuscularly or subcutaneously.
We see the need for a way to inject Insulin in a less invasive way than currently done, but our device is not suitable for that yet. We designed it to make sure that the fluid to be injected is spreaded in the tissue. Given what we know about Insulin therapies, we see a possibility for short-term Insulin but we have to think further about long-term Insulin.

We wanted to point out the puttholes in the road, but we consider this a very interesting topic. We are more than willing to discuss about it with representatives from Novo Nordisk.


Novartis A.G.

We are also interested in cooperating with Novo Nordisk, because we see many advantages of a synergy.
 
Joined
Feb 25, 2008
Messages
496
Novo Nordisk - Saving Lives Since 1902

While we regret that your new device is inapplicable to insulin delivery we completely understand and appreciate the limitations of new research. We would happily invest in a joint-study with you towards this end. We also look forward to a future synergistic relationship with your company.
 

Rheinbund

Established Nation
Joined
Oct 30, 2006
Messages
11,833
Location
Rotterdam, Netherlands
Capital
Fehrbellin
Press release

Medtronic announces the introduction of eye implants next year. With these eye implants, it will become possible for people with acquired blindness to see again.
 
Top